Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25
Closed -$2.46K 3734
2025
Q2
$2.46K Buy
25
+23
+1,150% +$2.18K ﹤0.01% 3077
2025
Q1
$182 Hold
2
﹤0.01% 3464
2024
Q4
$182 Hold
2
﹤0.01% 3459
2024
Q3
$193 Buy
+2
New +$195 ﹤0.01% 3360

Other funds holding AMED

Principal Securities's AMED Position: Q3 2025 in Review

Principal Securities sold out of Amedisys (AMED) in Q3 2025, closing a stake of 25 shares — an estimated $2.46K sold.

Principal Securities first reported a position in AMED in Q3 2024 and held it in 4 quarters. The position peaked at $2.46K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Principal Securities reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Principal Securities sold 25 Amedisys shares in Q3 2025, an estimated $2.46K.
  • Principal Securities first reported a position in Amedisys in Q3 2024 and held it in 4 quarters.
  • Principal Securities's Amedisys position peaked at $2.46K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Principal Securities's 13F filing for Q3 2025, filed 12 Nov 2025.